Study of COYA 302 for the Treatment of ALS
NCT07161999
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG:
COYA 302
DRUG:
Placebo
Sponsor
Coya Therapeutics